Study of improvement of allergic nasal symptoms by Bifidobacteria
Not Applicable
- Conditions
- one
- Registration Number
- JPRN-UMIN000039059
- Lead Sponsor
- KSO Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 140
Inclusion Criteria
Not provided
Exclusion Criteria
1) Subject who regularly take or took allergy medicine. 2) Subject with hepatic disease, renal dysfunction, cardiovascular disorder, gastrointestinal disorder, respiratory dysfunction, blood disease, autoimmune disease, endocrine disease, metabolic disease and these severe medical history (Excluding appendectomy). 3) Subject with serious allergy to specific medicine or food. 4) Subject who is pregnant or under lactation, or who is expected to be pregnant during the study. 5) Subject who takes part in other clinical study within the past month. 6) Subject who is ineligible due to physician's judgment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method asal symptom score (symptom score, medication score, symptom-medication score)
- Secondary Outcome Measures
Name Time Method Japanese Rhino-conjunctivitis Quality of Life Questionnaire (Items related to the nose)